Cepheid sees FY13 non-GAAP EPS 41c-46c, consensus 12c Sees FY13 revenue $375M-$385M, consensus $396.52M. Sees FY13net income to range from a net loss of (5c)-1c. Expected non-GAAP net income excludes approximately $29M related to stock compensation expense and approximately $4M related to the amortization of acquired intangibles. The fully diluted share count for the year is expected to be approximately 72M, except in the event of a GAAP loss where the share count would be approximately 67M shares.
News For CPHD From The Last 14 Days
Check below for free stories on CPHD the last two weeks.
On The Fly: Analyst Upgrade Summary Today's noteworthy upgrades include: AB InBev (BUD) upgraded to Hold from Sell at Societe Generale... Baker Hughes (BHI) upgraded to Outperform from Sector Perform at Howard Weil... Bank of the Ozarks (OZRK) upgraded to Buy from Hold at BB&T... Bill Barrett (BBG) upgraded to Buy from Neutral at Mizuho... Cepheid (CPHD) upgraded to Buy from Hold at Cantor... Cigna (CI) upgraded to Positive from Neutral at Susquehanna... Extra Space Storage (EXR) upgraded to Buy from Hold at Jefferies... GNC Holdings (GNC) upgraded to Outperform from Neutral at Wedbush... MB Financial (MBFI) upgraded at DA Davidson... Mondelez (MDLZ) upgraded to Buy from Hold at Societe Generale... Radian Group (RDN) upgraded to Buy from Neutral at Compass Point... Skullcandy (SKUL) assumed with a Overweight from Neutral at Piper Jaffray... Under Armour (UA) upgraded to Overweight from Neutral at Piper Jaffray.